FUSOSOME COMPOSITIONS AND USES THEREOF

RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN IMMUNIZING AGAINST SARS-COV-2 OMICRON VARIANT

USE OF CODON DEOPTIMISATION AND OPTIMISATION TO PRODUCE A LARYNGOTRACHEITIS VIRUS-ATTENUATED VACCINE

VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER

RECOMBINANT PROTEIN FOR DISPLAYING S PROTEIN OF SARS-COV-2, RECOMBINANT VIRION, AND USE THEREOF

RECOMBINANT HVT VECTORS EXPRESSING INFLUENZA HEMAGGLUTININ AND IMMUNOGENIC COMPOSITIONS, AND PRODUCTION AND USES THEREOF

CHIMERIC NEWCASTLE DISEASE VIRUS EXPRESSING APMV HN AND F PROTEINS

RECOMBINANT NEWCASTLE DISEASE VIRUS RNDV-VEGF-TRAP, GENOME THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF

METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)

RECOMBINANT HVT AND USES THEREOF

RECOMBINANT ONCOLYTIC NEWCASTLE DISEASE VIRUSES WITH INCREASED ACTIVITY

RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF

ENGINEERED NEWCASTLE DISEASE VIRUS VECTOR AND USES THEREOF

Oncolytic virus for treating brain tumors using recombinant Newcastle disease virus into which Newcastle disease virus vector-based PTEN gene is inserted and composition for treating brain tumors using same

NEW ONCOLYTIC NEWCASTLE DISEASE VIRUSES AND RECOMBINANT NDV STRAINS

RECOMBINANT ONCOLYTIC NEWCASTLE DISEASE VIRUSES WITH INCREASED ACTIVITY

Paramyxovirus vaccine strain for novel coronavirus pneumonia and construction method thereof

Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)

RECOMBINANT RSV LIVE VACCINE STRAIN AND PRODUCTION METHOD THEREFOR

VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER

FUSOSOME COMPOSITIONS AND USES THEREOF

INCREASED ACTIVITY OF ONCOLYTIC NEWCASTLE DISEASE VIRUS

Compositions featuring an attenuated newcastle disease virus and methods of use for treating neoplasia

Virus-like particle compositions and vaccines against epstein-barr virus infection and disease

Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)

VSV/NDV hybrid viruses for oncolytic therapy of cancer

Newcastle disease viruses and uses thereof

Newcastle Disease Viruses and Uses Thereof

Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease

Newcastle Disease Viruses And Uses Thereof

Chimeric viruses presenting non-native surface proteins and uses thereof

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

Compositions featuring an attenuated Newcastle disease virus and methods of use for treating neoplasia

Chimeric newcastle disease viruses and uses thereof

Heat-resistant newcastle disease virus live vaccine vector system and use thereof

Respiratory syncytial virus (RSV) sequences for protein expression and vaccines

Chimeric Newcastle disease viruses and uses thereof

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

Chimeric viruses presenting non-native surface proteins and uses thereof

Helper-free Rescue of Recombinant Negative Strand RNA Virus Systems

Chimeric Newcastle disease viruses and uses thereof

FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS

Respiratory synctial virus (RSV) sequences for protein expression and vaccines

Recombinant NDV antigen and uses thereof

Recombinant avian paramyxovirus vaccine and method for making and using thereof

RECOMBINANT NEWCASTLE DISEASE VIRUS

METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION

Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof

CHIMERIC NEWCASTLE DISEASE VIRUS VLPs

NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES

Attenuated recombinant newcastle disease virus and vaccine containing the same

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

COMPOSITIONS AND METHODS FOR TREATEMENT OF CANCER

Preparation of vaccine master cell lines using recombinant plant suspension cultures

Recombinant newcastle disease virus RNA expression systems and vaccines

Newcastle disease virus monoclonal antibodies

Methods for the propagation of modified influenza viruses in embryonated eggs

HN epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope

Recombinant negative strand RNA virus expression systems and vaccines

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

Promoter gene, recombinant turkey herpesvirus having the novel promoter gene, and poultry vaccine including the recombinant herpes virus of turkey

Recombinant Newcastle Disease Virus

Immunodeficiency recombinant poxvirus

Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids

Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier

Antigens

Preparation of vaccine master cell lines using recombinant plant suspension cultures

Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission

Recombinant negative strand virus RNA expression systems and vaccines

Escape mutants of newcastle disease virus as marker vaccines

Methods and interferon deficient substrates for the propagation of viruses

Compositions and methods for treatment of cancer

3 (MDV-2), a viral vector against different avian pathogens: a new vaccination strategy in the poultry industry